Assessment of factors associated with the quality of life of patients living with HIV/HCV co-infection

被引:0
|
作者
Marco Pereira
Renata Fialho
机构
[1] University of Coimbra,Faculty of Psychology and Educational Sciences
[2] University of Sussex,School of Psychology
[3] Sussex Partnership NHS Foundation Trust,undefined
来源
Journal of Behavioral Medicine | 2016年 / 39卷
关键词
Co-infection; HIV; HCV; Psychological symptoms; Quality of life;
D O I
暂无
中图分类号
学科分类号
摘要
This study compared the quality of life (QoL) of HIV-infected patients with and without hepatitis C and examined the sociodemographic, HIV-related and psychological symptoms associated with the QoL domains in patients with HIV/HCV co-infection. The sample consisted of 248 HIV/HCV co-infected patients (18–74 years, 81.5 % male) and 482 patients only with HIV (24–78 years, 62.7 % male). Participants completed the WHOQOL-HIV-Bref questionnaire and the Brief Symptom Inventory. The HIV/HCV co-infected patients reported significantly lower QoL in all domains, as well as significantly lower scores in 10 of the 17 specific facets. Overall, among the co-infected patients, male gender, employment, combination antiretroviral therapy use and fewer depressive and anxiety symptoms were significantly associated with higher QoL. Symptoms of psychological distress accounted for significant variability in the QoL scores of co-infected patients. These data reinforce the need for tailored interventions to improve the overall well-being of HIV/HCV co-infected patients.
引用
收藏
页码:767 / 781
页数:14
相关论文
共 50 条
  • [11] HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications
    Andreoni, M.
    Giacometti, A.
    Maida, I.
    Meraviglia, P.
    Ripamonti, D.
    Sarmati, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (11) : 1473 - 1483
  • [12] Epidemiological Profile and Risk Factors of HIV and HBV/HCV Co-Infection in Fujian Province, Southeastern China
    Wu, Shouli
    Yan, Pingping
    Yang, Tianfei
    Wang, Zhenghua
    Yan, Yansheng
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (03) : 443 - 449
  • [13] Prevalence and associated factors of HIV-TB co-infection among HIV patients: a retrospective Study
    Zeru, Melkamu A.
    AFRICAN HEALTH SCIENCES, 2021, 21 (03) : 1003 - 1009
  • [14] Tuberculosis and HIV Co-infection and associated factors among HIV reactive patients in Ethiopia
    Fite, Robera Olana
    Chichiabellu, Tesfaye Yitna
    Demissie, Birhanu Wondimeneh
    Hanfore, Lolemo Kelbiso
    JOURNAL OF NURSING AND MIDWIFERY SCIENCES, 2019, 6 (01) : 15 - 20
  • [15] The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker
    Yousefpouran, Sepehr
    Mostafaei, Shayan
    Manesh, Pegah Vahidi
    Iranifar, Elmira
    Bokharaei-Salim, Farah
    Nahand, Javid Sadri
    Mirzaei, Hamed
    Taran, Mojtaba
    Babaei, Farhad
    Sayad, Babak
    Moghoofei, Mohsen
    MICROBIAL PATHOGENESIS, 2020, 147
  • [16] New frontiers of HCV therapy in HIV/HCV co-infection
    Amorosa V.K.
    Current HIV/AIDS Reports, 2010, 7 (3) : 117 - 126
  • [17] HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
    Leyna, Germana Henry
    Makyao, Neema
    Mwijage, Alexander
    Ramadhan, Angela
    Likindikoki, Samuel
    Mizinduko, Mucho
    Leshabari, Melkizedeck Thomas
    Moen, Kare
    Mmbaga, Elia John
    HARM REDUCTION JOURNAL, 2019, 16 (01)
  • [18] HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection
    Denholm, J. T.
    Wright, E. J.
    Street, A.
    Sasadeusz, J. J.
    HAEMOPHILIA, 2009, 15 (02) : 538 - 543
  • [19] Impact of HIV on Genomic Variability in the 5′UTR of HCV in Indian Patients with HCV/HIV Co-Infection
    Chaudhary, Artee
    Kukreti, Himani
    Pasha, Syed Tazeen
    Gupta, Sunil
    Kumari, Manisha
    Khare, Shashi
    Lal, Shiv
    Rai, Arvind
    INTERVIROLOGY, 2008, 51 (04) : 224 - 229
  • [20] Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection
    Reiberger, T.
    Rasoul-Rockenschaub, S.
    Rieger, A.
    Ferenci, P.
    Gangl, A.
    Peck-Radosavljevic, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (06) : 421 - 429